Found: 15
Select item for more details and to access through your institution.
Brain Metastases from Genito-Urinary Cancers in the Canton of Geneva (Switzerland): Study of Incidence, Management and Outcomes.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3437, doi. 10.3390/cancers16203437
- By:
- Publication type:
- Article
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02258-z
- By:
- Publication type:
- Article
Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
- Published in:
- Journal of Pathology, 2009, v. 219, n. 4, p. 491, doi. 10.1002/path.2622
- By:
- Publication type:
- Article
The Leucine-Rich Repeat-Containing G ProteinCoupled Receptor 8 Gene T222P Mutation Does Not Cause Cryptorchidism.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 3, p. 1072, doi. 10.1210/jc.2007-1993
- By:
- Publication type:
- Article
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 464, doi. 10.3390/cancers11040464
- By:
- Publication type:
- Article
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 7, p. 923, doi. 10.1093/neuonc/noz040
- By:
- Publication type:
- Article
An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin.
- Published in:
- Biology (2079-7737), 2020, v. 9, n. 9, p. 264, doi. 10.3390/biology9090264
- By:
- Publication type:
- Article
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 9, p. 1, doi. 10.1038/s41419-023-06117-z
- By:
- Publication type:
- Article
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0162105
- By:
- Publication type:
- Article
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149099
- By:
- Publication type:
- Article
Live-cell delamination counterbalances epithelial growth to limit tissue overcrowding.
- Published in:
- Nature, 2012, v. 484, n. 7395, p. 542, doi. 10.1038/nature10984
- By:
- Publication type:
- Article
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00089
- By:
- Publication type:
- Article
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice